Adaptive Biotechnologies Corp (NAS:ADPT)
$ 3.65 0.21 (6.1%) Market Cap: 537.89 Mil Enterprise Value: 294.57 Mil PE Ratio: 0 PB Ratio: 1.95 GF Score: 72/100

Q2 2020 Adaptive Biotechnologies Corp Earnings Call Transcript

Aug 10, 2020 / 08:30PM GMT
Release Date Price: $37.6 (-1.62%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Adaptive Biotechnologies Second Quarter Financial Results Conference Call. (Operator Instructions)

I would now like to hand the call over to your speaker today, Ms. Karina Calzadilla. Please go ahead.

Karina Calzadilla;Vice President Investor Relations

Thank you, Keno, and good afternoon, everyone. I would like to welcome you to Adaptive Biotechnologies Second Quarter 2020 Earnings Conference Call. Earlier today, we issued a press release reporting Adaptive's financial results for the second quarter of 2020. The press release is available on our corporate website at www.adaptivebiotech.com.

We are conducting a live webcast of this call, a replay of which will be available on our website after its conclusion. I would also like to remind you that during the call, management will make projections and other forward-looking statements within the meaning of federal securities laws regarding future

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot